What is the global market size of Patient Blood Management Market?

Patient Blood Management Market size was valued at USD 12.2 billion in 2021 and is poised to grow from USD 12.97 billion in 2022 to USD 21.14 billion by 2030, growing at a CAGR of 6.3% during the forecast period (2023-2030).

Who are the key vendors in the Global Patient Blood Management Market?

The global patient blood management market is highly competitive and dynamic, characterized by the presence of several key players operating in the healthcare industry. Patient blood management refers to a multidisciplinary approach that aims to optimize patient outcomes by effectively managing and preserving the patient's own blood. This includes strategies such as minimizing blood loss, optimizing red blood cell production, and utilizing alternative therapies to transfusion. 'Fresenius SE & Co. KGaA (Germany)', 'Haemonetics Corporation (US)', 'Terumo Corporation (Japan)', 'B. Braun Melsungen AG (Germany)', 'Bio-Rad Laboratories, Inc. (US)', 'LivaNova PLC (UK)', 'Medtronic PLC (Ireland)', 'Abbott Laboratories (US)', 'Grifols, S.A. (Spain)', 'F. Hoffmann-La Roche Ltd (Switzerland)', 'Danaher Corporation (US)', 'Immucor, Inc. (US)', 'BioMérieux SA (France)', 'Ortho Clinical Diagnostics (US)', 'Fresenius Kabi AG (Germany)', 'Kedrion S.p.A. (Italy)', 'Octapharma AG (Switzerland)', 'Beckman Coulter, Inc. (US)', 'Siemens Healthineers AG (Germany)', 'Quidel Corporation (US)'.

Patient Blood Management Market Size, Share, Growth Analysis, By Product (Instruments, Blood Processing Devices), By Component (Whole Blood, Blood Components), By End User (Hospitals, Blood Banks), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35D2100 | Region: Global | Published Date: December, 2024
Pages: 157 | Tables: 61 | Figures: 75

Patient Blood Management Market Dynamics

Patient Blood Management Market Drivers

Advancements in transfusion medicine

The field of transfusion medicine has experienced notable progress, marked by the emergence of novel techniques and technologies for blood management. These advancements have significantly improved the safety and effectiveness of blood transfusions, thereby encouraging the adoption of patient blood management practices.

Patient Blood Management Market Restraints

Challenges in changing transfusion practices

The implementation of patient blood management practices often necessitates a departure from established transfusion methods and medical norms. Overcoming resistance to change, accommodating physician preferences, and providing adequate training and education present challenges to the widespread acceptance of patient blood management approaches.

Patient Blood Management Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Patient Blood Management Market size was valued at USD 13.79 Billion in 2023 and is poised to grow from USD 14.66 Billion in 2024 to USD 23.9 Billion by 2032, growing at a CAGR of 6.30% during the forecast period (2025-2032).

The global patient blood management market is highly competitive and dynamic, characterized by the presence of several key players operating in the healthcare industry. Patient blood management refers to a multidisciplinary approach that aims to optimize patient outcomes by effectively managing and preserving the patient's own blood. This includes strategies such as minimizing blood loss, optimizing red blood cell production, and utilizing alternative therapies to transfusion. 'Haemonetics Corporation (USA) ', 'Macopharma (France) ', 'Terumo Corporation (Japan) ', 'B. Braun SE (Germany) ', 'Grifols, S.A. (Spain) ', 'Asahi Kasei Corporation (Japan) ', 'BioMérieux SA (France) ', 'LivaNova PLC (UK) ', 'Fresenius Kabi AG (Germany) ', 'Roche Holding AG (Switzerland) ', 'Abbott Laboratories (USA) ', 'Bio-Rad Laboratories, Inc. (USA) ', 'Danaher Corporation (USA) ', 'Siemens Healthineers (Germany) ', 'Johnson & Johnson (USA) ', 'Medtronic plc. (Ireland) ', 'BD (Becton, Dickinson and Company) (USA) ', 'Cardinal Health (USA) ', 'Teleflex Incorporated (USA) ', 'Stryker Corporation (USA) '

The field of transfusion medicine has experienced notable progress, marked by the emergence of novel techniques and technologies for blood management. These advancements have significantly improved the safety and effectiveness of blood transfusions, thereby encouraging the adoption of patient blood management practices.

One significant market trend in the global patient blood management market is the increasing focus on personalized and evidence-based approaches to optimize blood transfusion practices. This trend emphasizes the importance of tailoring blood transfusion strategies to individual patients based on their specific needs and clinical conditions, rather than adopting a one-size-fits-all approach. Healthcare providers and organizations are recognizing the potential risks and complications associated with unnecessary blood transfusions, such as transfusion reactions, infections, and increased healthcare costs.

North America dominated the global patient blood management market. North America holds a significant share in the market due to the presence of advanced healthcare infrastructure, well-established healthcare systems, and a high level of awareness about patient blood management practices. Countries like the US and Canada have implemented stringent regulations and guidelines to promote safe and effective blood management, driving the market growth in the region. Additionally, technological advancements and a strong focus on research and development contribute to the dominance of North America in the patient blood management market.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Patient Blood Management Market Size, Share, Growth Analysis, By Product (Instruments, Blood Processing Devices), By Component (Whole Blood, Blood Components), By End User (Hospitals, Blood Banks), By Region - Industry Forecast 2024-2031

Patient Blood Management Market Dynamics

Patient Blood Management Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Patient Blood Management Market?

Who are the key vendors in the Patient Blood Management Market?

What is the key driver of Patient Blood Management Market?

What is the key market trend for Patient Blood Management Market?

Which region accounted for the largest share in Patient Blood Management Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300